查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1602721

肛瘘治疗市场：依治疗类型、肛门瘘类型、最终用户划分 - 全球预测 2025-2030

Anal Fistula Treatment Market by Treatment Type (Non-Surgical, Surgical), Fistula Type (Intersphincteric Fistula, Suprasphincteric Fistula, Transsphincteric Fistula), End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年，痔疮治疗市场价值为6.5139亿美元，预计到2024年将达到6.7552亿美元，复合年增长率为4.87%，到2030年将达到9.091亿美元。

肛瘘治疗市场围绕着旨在治疗肛门瘘的医疗干预措施，肛瘘是肛管和皮肤之间的异常连接。由于肛瘘带来的不适、潜在併发症和高復发率，因此需要有效的治疗方案，这凸显了对创新和有效治疗方案的迫切需求。应用范围和最终用途主要包括医院、诊所和专科手术中心，其中先进的外科手术如瘻管塞、LIFT（括约肌间瘻管结扎术）、VAAFT（视讯辅助肛瘘治疗）和微创技术正在获得应用受欢迎程度。市场成长受到手术技术进步、肛门疾病盛行率增加以及对直肠健康意识不断增强等因素的影响。新的商机包括开发用于外科植入的新型生物材料以及增强微创手术以降低復发和术后併发症的风险。利用这些机会的主要建议包括促进与医学研究机构的合作以及增加研发投资以产生具有成本效益的解决方案。然而，仍存在一些挑战，包括手术的复杂性、失禁的风险以及缺乏获得专门护理的机会，特别是在低收入地区。创新可以集中在更安全的手术黏剂、用于更好诊断的影像技术的进步以及针对患者特定肛门瘘特征的个人化医疗方法。该市场是由医疗保健支出增加和技术创新推动的，但成长受到认识有限和潜在治疗副作用的限制。相关人员应优先考虑教育倡议并制定应对临床挑战的策略，以确保尖端解决方案保持可近性和有效性。

主要市场统计
基准年[2023] 65139万美元
预测年份 [2024] 67552万美元
预测年份 [2030] 9.091 亿美元
复合年增长率（%） 4.87%

市场动态：揭示快速发展的肛瘘治疗市场的关键市场洞察

供需的动态交互作用正在改变痔疮治疗市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助企业了解消费行为及其对製造业的影响。

  • 市场驱动因素
    • 全球痔疮盛行率不断上升
    • 倾向微创手术
    • 提高肛瘘治疗药物和治疗方法的核准率
  • 市场限制因素
    • 肛瘘治疗高成本
  • 市场机会
    • 采用治疗方法
    • 用于开发增强药物和治疗方法的大量投资和资金筹措
  • 市场问题
    • 肛瘘治疗相关併发症

波特五力：驾驭肛门瘘治疗市场的策略工具

波特的五力框架是了解肛门瘘治疗市场竞争格局的关键工具。波特的五力框架描述了评估公司竞争和探索策略机会的清晰方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解肛门瘘治疗市场的外在影响

外部宏观环境因素在塑造肛瘘治疗市场的绩效动态发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助企业预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析：了解肛瘘治疗市场的竞争状况

对痔疮治疗市场的详细市场占有率分析可以对供应商的表现进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、细分和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵：肛门瘘治疗市场供应商的绩效评估

FPNV 定位矩阵是评估肛门瘘治疗市场供应商的重要工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，以确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议：规划肛瘘治疗市场的成功之路

对于旨在加强在全球市场的影响力的公司来说，对痔疮治疗市场的策略分析至关重要。透过考虑关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

该报告对涵盖关键焦点细分市场的市场进行了全面分析。

1.市场渗透率：对当前市场环境的详细审查，主要企业的广泛资料，评估他们在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有细分市场的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策。

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品和地区提供最佳投资机会？

3.塑造市场的关键技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 世界各地肛瘘的盛行率正在增加。
      • 微创手术趋势
      • 提高肛瘘治疗药物和治疗方法的核准率
    • 抑制因素
      • 治疗痔疮费用高
    • 机会
      • 采用新的肛门瘘治疗方法
      • 用于开发增强药物和治疗方法的大量投资和资金
    • 任务
      • 肛瘘治疗相关併发症
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治
    • 经济
    • 社会
    • 科技
    • 法律
    • 环境

第六章肛瘘治疗市场：依治疗类型

  • 介绍
  • 非手术手术
  • 外科手术

第七章肛瘘治疗市场：按肛瘘类型

  • 介绍
  • 括约肌间肛门瘘
  • 肛门上括约肌肛瘘
  • 括约肌穿透性肛门瘘

第八章肛瘘治疗市场：依最终使用者分类

  • 介绍
  • 门诊手术中心
  • 医院

第九章北美和南美肛门瘘治疗市场

  • 介绍
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十章亚太肛瘘治疗市场

  • 介绍
  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章欧洲、中东和非洲肛门瘘治疗市场

  • 介绍
  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Cook Group Incorporated
  • Integra LifeSciences Corporation
  • Johnson & Johnson Services, Inc.
  • KARL STORZ SE & Co. KG
  • Novartis AG
  • Pfizer Inc.
  • Signum Surgical
  • Surtex Instruments Limited
  • Takeda Pharmaceutical Company Limited
  • THD SpA
  • WL Gore & Associates, Inc.
Product Code: MRR-8E22B61932B3

The Anal Fistula Treatment Market was valued at USD 651.39 million in 2023, expected to reach USD 675.52 million in 2024, and is projected to grow at a CAGR of 4.87%, to USD 909.10 million by 2030.

The anal fistula treatment market revolves around medical interventions aimed at managing anal fistulas, which are abnormal connections between the anal canal and the skin. The necessity for effective treatment solutions is driven by the discomfort, potential complications, and high recurrence rates associated with anal fistulas, highlighting the critical need for innovative and efficient therapeutic options. The application and end-use scope primarily involve hospitals, clinics, and specialty surgery centers, where advanced surgical procedures and minimally invasive techniques such as Fistula Plug, LIFT (Ligation of Intersphincteric Fistula Tract), and VAAFT (Video Assisted Anal Fistula Treatment) are gaining traction. Market growth is influenced by factors such as technological advancements in surgical techniques, increasing prevalence of anal conditions, and greater awareness of rectal health. Emerging opportunities include the development of novel biomaterials for surgical implants and enhanced minimally invasive procedures, which may present less risk of recurrence and post-operative complications. Key recommendations to harness these opportunities involve fostering collaboration with medical research institutions and increasing investment in R&D to create cost-effective solutions. However, several challenges persist, such as the complexity of surgical procedures, risk of incontinence, and lack of widespread access to specialized treatment, especially in low-income regions. Innovation could focus on the formulation of safer surgical adhesives, advances in imaging techniques for better diagnosis, and personalized medicine approaches that address patient-specific fistula characteristics. The market is anticipated to evolve, driven by growing healthcare expenditure and technological innovation, yet its growth is curtailed by limited awareness and potential side effects of treatments. Stakeholders should prioritize educational initiatives and develop strategies to address clinical challenges, ensuring that cutting-edge solutions remain approachable and effective.

KEY MARKET STATISTICS
Base Year [2023] USD 651.39 million
Estimated Year [2024] USD 675.52 million
Forecast Year [2030] USD 909.10 million
CAGR (%) 4.87%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Anal Fistula Treatment Market

The Anal Fistula Treatment Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increase in prevalence of anal fistula among individuals worldwide
    • Inclination towards minimally invasive surgical procedure
    • Rise in approval rate for drugs and therapies for anal fistula treatment
  • Market Restraints
    • High cost of anal fistula treatment
  • Market Opportunities
    • Introduction of novel treatments for anal fistula
    • Significant investment and funding for development of enhanced drugs and treatments
  • Market Challenges
    • Complications associated with anal fistula treatment

Porter's Five Forces: A Strategic Tool for Navigating the Anal Fistula Treatment Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Anal Fistula Treatment Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Anal Fistula Treatment Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Anal Fistula Treatment Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Anal Fistula Treatment Market

A detailed market share analysis in the Anal Fistula Treatment Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Anal Fistula Treatment Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Anal Fistula Treatment Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Anal Fistula Treatment Market

A strategic analysis of the Anal Fistula Treatment Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Anal Fistula Treatment Market, highlighting leading vendors and their innovative profiles. These include Cook Group Incorporated, Integra LifeSciences Corporation, Johnson & Johnson Services, Inc., KARL STORZ SE & Co. KG, Novartis AG, Pfizer Inc., Signum Surgical, Surtex Instruments Limited, Takeda Pharmaceutical Company Limited, THD SpA, and W. L. Gore & Associates, Inc..

Market Segmentation & Coverage

This research report categorizes the Anal Fistula Treatment Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Treatment Type, market is studied across Non-Surgical and Surgical.
  • Based on Fistula Type, market is studied across Intersphincteric Fistula, Suprasphincteric Fistula, and Transsphincteric Fistula.
  • Based on End User, market is studied across Ambulatory Surgical Centers and Hospitals.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increase in prevalence of anal fistula among individuals worldwide
      • 5.1.1.2. Inclination towards minimally invasive surgical procedure
      • 5.1.1.3. Rise in approval rate for drugs and therapies for anal fistula treatment
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of anal fistula treatment
    • 5.1.3. Opportunities
      • 5.1.3.1. Introduction of novel treatments for anal fistula
      • 5.1.3.2. Significant investment and funding for development of enhanced drugs and treatments
    • 5.1.4. Challenges
      • 5.1.4.1. Complications associated with anal fistula treatment
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Anal Fistula Treatment Market, by Treatment Type

  • 6.1. Introduction
  • 6.2. Non-Surgical
  • 6.3. Surgical

7. Anal Fistula Treatment Market, by Fistula Type

  • 7.1. Introduction
  • 7.2. Intersphincteric Fistula
  • 7.3. Suprasphincteric Fistula
  • 7.4. Transsphincteric Fistula

8. Anal Fistula Treatment Market, by End User

  • 8.1. Introduction
  • 8.2. Ambulatory Surgical Centers
  • 8.3. Hospitals

9. Americas Anal Fistula Treatment Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Anal Fistula Treatment Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Anal Fistula Treatment Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Cook Group Incorporated
  • 2. Integra LifeSciences Corporation
  • 3. Johnson & Johnson Services, Inc.
  • 4. KARL STORZ SE & Co. KG
  • 5. Novartis AG
  • 6. Pfizer Inc.
  • 7. Signum Surgical
  • 8. Surtex Instruments Limited
  • 9. Takeda Pharmaceutical Company Limited
  • 10. THD SpA
  • 11. W. L. Gore & Associates, Inc.

LIST OF FIGURES

  • FIGURE 1. ANAL FISTULA TREATMENT MARKET RESEARCH PROCESS
  • FIGURE 2. ANAL FISTULA TREATMENT MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL ANAL FISTULA TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL ANAL FISTULA TREATMENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL ANAL FISTULA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL ANAL FISTULA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL ANAL FISTULA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL ANAL FISTULA TREATMENT MARKET SIZE, BY FISTULA TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL ANAL FISTULA TREATMENT MARKET SIZE, BY FISTULA TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL ANAL FISTULA TREATMENT MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL ANAL FISTULA TREATMENT MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS ANAL FISTULA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS ANAL FISTULA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES ANAL FISTULA TREATMENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES ANAL FISTULA TREATMENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC ANAL FISTULA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC ANAL FISTULA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA ANAL FISTULA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ANAL FISTULA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. ANAL FISTULA TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. ANAL FISTULA TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. ANAL FISTULA TREATMENT MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL ANAL FISTULA TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ANAL FISTULA TREATMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL ANAL FISTULA TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. ANAL FISTULA TREATMENT MARKET DYNAMICS
  • TABLE 7. GLOBAL ANAL FISTULA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL ANAL FISTULA TREATMENT MARKET SIZE, BY NON-SURGICAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL ANAL FISTULA TREATMENT MARKET SIZE, BY SURGICAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL ANAL FISTULA TREATMENT MARKET SIZE, BY FISTULA TYPE, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL ANAL FISTULA TREATMENT MARKET SIZE, BY INTERSPHINCTERIC FISTULA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL ANAL FISTULA TREATMENT MARKET SIZE, BY SUPRASPHINCTERIC FISTULA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL ANAL FISTULA TREATMENT MARKET SIZE, BY TRANSSPHINCTERIC FISTULA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL ANAL FISTULA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL ANAL FISTULA TREATMENT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL ANAL FISTULA TREATMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS ANAL FISTULA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS ANAL FISTULA TREATMENT MARKET SIZE, BY FISTULA TYPE, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS ANAL FISTULA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS ANAL FISTULA TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 21. ARGENTINA ANAL FISTULA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 22. ARGENTINA ANAL FISTULA TREATMENT MARKET SIZE, BY FISTULA TYPE, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA ANAL FISTULA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 24. BRAZIL ANAL FISTULA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 25. BRAZIL ANAL FISTULA TREATMENT MARKET SIZE, BY FISTULA TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL ANAL FISTULA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 27. CANADA ANAL FISTULA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. CANADA ANAL FISTULA TREATMENT MARKET SIZE, BY FISTULA TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA ANAL FISTULA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 30. MEXICO ANAL FISTULA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. MEXICO ANAL FISTULA TREATMENT MARKET SIZE, BY FISTULA TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO ANAL FISTULA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 33. UNITED STATES ANAL FISTULA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. UNITED STATES ANAL FISTULA TREATMENT MARKET SIZE, BY FISTULA TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES ANAL FISTULA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES ANAL FISTULA TREATMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 37. ASIA-PACIFIC ANAL FISTULA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. ASIA-PACIFIC ANAL FISTULA TREATMENT MARKET SIZE, BY FISTULA TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC ANAL FISTULA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC ANAL FISTULA TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 41. AUSTRALIA ANAL FISTULA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. AUSTRALIA ANAL FISTULA TREATMENT MARKET SIZE, BY FISTULA TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. AUSTRALIA ANAL FISTULA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 44. CHINA ANAL FISTULA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. CHINA ANAL FISTULA TREATMENT MARKET SIZE, BY FISTULA TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. CHINA ANAL FISTULA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 47. INDIA ANAL FISTULA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. INDIA ANAL FISTULA TREATMENT MARKET SIZE, BY FISTULA TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA ANAL FISTULA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 50. INDONESIA ANAL FISTULA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. INDONESIA ANAL FISTULA TREATMENT MARKET SIZE, BY FISTULA TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA ANAL FISTULA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 53. JAPAN ANAL FISTULA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. JAPAN ANAL FISTULA TREATMENT MARKET SIZE, BY FISTULA TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. JAPAN ANAL FISTULA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 56. MALAYSIA ANAL FISTULA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. MALAYSIA ANAL FISTULA TREATMENT MARKET SIZE, BY FISTULA TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. MALAYSIA ANAL FISTULA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 59. PHILIPPINES ANAL FISTULA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. PHILIPPINES ANAL FISTULA TREATMENT MARKET SIZE, BY FISTULA TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. PHILIPPINES ANAL FISTULA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 62. SINGAPORE ANAL FISTULA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. SINGAPORE ANAL FISTULA TREATMENT MARKET SIZE, BY FISTULA TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. SINGAPORE ANAL FISTULA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 65. SOUTH KOREA ANAL FISTULA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. SOUTH KOREA ANAL FISTULA TREATMENT MARKET SIZE, BY FISTULA TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. SOUTH KOREA ANAL FISTULA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 68. TAIWAN ANAL FISTULA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. TAIWAN ANAL FISTULA TREATMENT MARKET SIZE, BY FISTULA TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. TAIWAN ANAL FISTULA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 71. THAILAND ANAL FISTULA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. THAILAND ANAL FISTULA TREATMENT MARKET SIZE, BY FISTULA TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. THAILAND ANAL FISTULA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 74. VIETNAM ANAL FISTULA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. VIETNAM ANAL FISTULA TREATMENT MARKET SIZE, BY FISTULA TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. VIETNAM ANAL FISTULA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 77. EUROPE, MIDDLE EAST & AFRICA ANAL FISTULA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. EUROPE, MIDDLE EAST & AFRICA ANAL FISTULA TREATMENT MARKET SIZE, BY FISTULA TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA ANAL FISTULA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA ANAL FISTULA TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 81. DENMARK ANAL FISTULA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. DENMARK ANAL FISTULA TREATMENT MARKET SIZE, BY FISTULA TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. DENMARK ANAL FISTULA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 84. EGYPT ANAL FISTULA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. EGYPT ANAL FISTULA TREATMENT MARKET SIZE, BY FISTULA TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. EGYPT ANAL FISTULA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 87. FINLAND ANAL FISTULA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. FINLAND ANAL FISTULA TREATMENT MARKET SIZE, BY FISTULA TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. FINLAND ANAL FISTULA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 90. FRANCE ANAL FISTULA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. FRANCE ANAL FISTULA TREATMENT MARKET SIZE, BY FISTULA TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. FRANCE ANAL FISTULA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 93. GERMANY ANAL FISTULA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. GERMANY ANAL FISTULA TREATMENT MARKET SIZE, BY FISTULA TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. GERMANY ANAL FISTULA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 96. ISRAEL ANAL FISTULA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. ISRAEL ANAL FISTULA TREATMENT MARKET SIZE, BY FISTULA TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. ISRAEL ANAL FISTULA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 99. ITALY ANAL FISTULA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. ITALY ANAL FISTULA TREATMENT MARKET SIZE, BY FISTULA TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. ITALY ANAL FISTULA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 102. NETHERLANDS ANAL FISTULA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. NETHERLANDS ANAL FISTULA TREATMENT MARKET SIZE, BY FISTULA TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. NETHERLANDS ANAL FISTULA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 105. NIGERIA ANAL FISTULA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. NIGERIA ANAL FISTULA TREATMENT MARKET SIZE, BY FISTULA TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. NIGERIA ANAL FISTULA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 108. NORWAY ANAL FISTULA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. NORWAY ANAL FISTULA TREATMENT MARKET SIZE, BY FISTULA TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. NORWAY ANAL FISTULA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 111. POLAND ANAL FISTULA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. POLAND ANAL FISTULA TREATMENT MARKET SIZE, BY FISTULA TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. POLAND ANAL FISTULA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 114. QATAR ANAL FISTULA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. QATAR ANAL FISTULA TREATMENT MARKET SIZE, BY FISTULA TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. QATAR ANAL FISTULA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 117. RUSSIA ANAL FISTULA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. RUSSIA ANAL FISTULA TREATMENT MARKET SIZE, BY FISTULA TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. RUSSIA ANAL FISTULA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 120. SAUDI ARABIA ANAL FISTULA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. SAUDI ARABIA ANAL FISTULA TREATMENT MARKET SIZE, BY FISTULA TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. SAUDI ARABIA ANAL FISTULA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 123. SOUTH AFRICA ANAL FISTULA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH AFRICA ANAL FISTULA TREATMENT MARKET SIZE, BY FISTULA TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH AFRICA ANAL FISTULA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 126. SPAIN ANAL FISTULA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. SPAIN ANAL FISTULA TREATMENT MARKET SIZE, BY FISTULA TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. SPAIN ANAL FISTULA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 129. SWEDEN ANAL FISTULA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. SWEDEN ANAL FISTULA TREATMENT MARKET SIZE, BY FISTULA TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. SWEDEN ANAL FISTULA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 132. SWITZERLAND ANAL FISTULA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. SWITZERLAND ANAL FISTULA TREATMENT MARKET SIZE, BY FISTULA TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. SWITZERLAND ANAL FISTULA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 135. TURKEY ANAL FISTULA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. TURKEY ANAL FISTULA TREATMENT MARKET SIZE, BY FISTULA TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. TURKEY ANAL FISTULA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 138. UNITED ARAB EMIRATES ANAL FISTULA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. UNITED ARAB EMIRATES ANAL FISTULA TREATMENT MARKET SIZE, BY FISTULA TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED ARAB EMIRATES ANAL FISTULA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED KINGDOM ANAL FISTULA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED KINGDOM ANAL FISTULA TREATMENT MARKET SIZE, BY FISTULA TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM ANAL FISTULA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 144. ANAL FISTULA TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 145. ANAL FISTULA TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023